Federated Hermes
CGON icon

Federated Hermes’s CG Oncology CGON Stock Holding History

Federated Hermes’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.1M Buy
311,236
+162,486
+109% +$10.6M 0.03% 474
2026
Q1 		$10.1M Buy
148,750
+145,250
+4,150% +$8.23M 0.02% 637
2025
Q4 		$145K Sell
3,500
-3,100
-47% -$128K ﹤0.01% 1544
2025
Q3 		$266K Sell
6,600
-3,600
-35% -$105K ﹤0.01% 1464
2025
Q2 		$265K Buy
10,200
+1,700
+20% +$41K ﹤0.01% 1453
2025
Q1 		$208K Buy
8,500
+2,500
+42% +$70.3K ﹤0.01% 1480
2024
Q4 		$172K Buy
+6,000
New +$205K ﹤0.01% 1503

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Federated Hermes's CGON Position: Q2 2026 in Review

Federated Hermes increased its CG Oncology (CGON) stake by 109% in Q2 2026, buying an estimated $10.6M and bringing the position to 311,236 shares worth $22.1M. The position accounts for 0.03% of the portfolio, ranked #474.

Federated Hermes first reported a position in CGON in Q4 2024 and has held it in 7 quarters since. 227 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • Federated Hermes held 311,236 shares of CG Oncology worth $22.1M as of Q2 2026.
  • Federated Hermes bought 162,486 CG Oncology shares in Q2 2026, an estimated $10.6M.
  • CG Oncology made up 0.03% of Federated Hermes's portfolio in Q2 2026, its #474 holding.
  • Federated Hermes first reported a position in CG Oncology in Q4 2024 and has held it in 7 quarters since.
  • 227 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.